These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15923664)

  • 1. Mapping of the interface between leptin and the leptin receptor CRH2 domain.
    Iserentant H; Peelman F; Defeau D; Vandekerckhove J; Zabeau L; Tavernier J
    J Cell Sci; 2005 Jun; 118(Pt 11):2519-27. PubMed ID: 15923664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin.leptin receptor complex.
    Peelman F; Iserentant H; De Smet AS; Vandekerckhove J; Zabeau L; Tavernier J
    J Biol Chem; 2006 Jun; 281(22):15496-504. PubMed ID: 16540470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the leptin binding sites and design of a leptin antagonist.
    Peelman F; Van Beneden K; Zabeau L; Iserentant H; Ulrichts P; Defeau D; Verhee A; Catteeuw D; Elewaut D; Tavernier J
    J Biol Chem; 2004 Sep; 279(39):41038-46. PubMed ID: 15213225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains.
    Zabeau L; Defeau D; Iserentant H; Vandekerckhove J; Peelman F; Tavernier J
    J Biol Chem; 2005 Jun; 280(24):22632-40. PubMed ID: 15840566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists.
    Niv-Spector L; Gonen-Berger D; Gourdou I; Biener E; Gussakovsky EE; Benomar Y; Ramanujan KV; Taouis M; Herman B; Callebaut I; Djiane J; Gertler A
    Biochem J; 2005 Oct; 391(Pt 2):221-30. PubMed ID: 15952938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor.
    Niv-Spector L; Raver N; Friedman-Einat M; Grosclaude J; Gussakovsky EE; Livnah O; Gertler A
    Biochem J; 2005 Sep; 390(Pt 2):475-84. PubMed ID: 15842201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of leptin receptor N-linked glycans to leptin binding.
    Kamikubo Y; Dellas C; Loskutoff DJ; Quigley JP; Ruggeri ZM
    Biochem J; 2008 Mar; 410(3):595-604. PubMed ID: 17983356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of leptin binding domain in the leptin receptor.
    Fong TM; Huang RR; Tota MR; Mao C; Smith T; Varnerin J; Karpitskiy VV; Krause JE; Van der Ploeg LH
    Mol Pharmacol; 1998 Feb; 53(2):234-40. PubMed ID: 9463481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of naturally occurring pathogenic mutations in the human leptin receptor.
    Kimber W; Peelman F; Prieur X; Wangensteen T; O'Rahilly S; Tavernier J; Farooqi IS
    Endocrinology; 2008 Dec; 149(12):6043-52. PubMed ID: 18703626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5.
    Bolger GB; McCahill A; Yarwood SJ; Steele MR; Warwicker J; Houslay MD
    BMC Biochem; 2002 Aug; 3():24. PubMed ID: 12193273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of non-competitive leptin antagonists using a random nanobody-based approach.
    Zabeau L; Verhee A; Catteeuw D; Faes L; Seeuws S; Decruy T; Elewaut D; Peelman F; Tavernier J
    Biochem J; 2012 Jan; 441(1):425-34. PubMed ID: 21851341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20 years of leptin: insights into signaling assemblies of the leptin receptor.
    Peelman F; Zabeau L; Moharana K; Savvides SN; Tavernier J
    J Endocrinol; 2014 Oct; 223(1):T9-23. PubMed ID: 25063754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies.
    Rominger DH; Rominger CM; Fitzgerald LW; Grzanna R; Largent BL; Zaczek R
    J Pharmacol Exp Ther; 1998 Jul; 286(1):459-68. PubMed ID: 9655891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel leptin receptor variant with a conservative amino acid substitution (I359 V) in body weight selected and unselected mouse lines.
    Reichart U; Renne U; Aigner B; Kratzsch J; Brockmann GA
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):283-7. PubMed ID: 12951635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
    Voisin MB; Bitard J; Daburon S; Moreau JF; Taupin JL
    J Biol Chem; 2002 Apr; 277(16):13682-92. PubMed ID: 11834739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the putative G protein-coupled receptor (GPCR) docking site on GPCR kinase 2: insights from intact cell phosphorylation and recruitment assays.
    Beautrait A; Michalski KR; Lopez TS; Mannix KM; McDonald DJ; Cutter AR; Medina CB; Hebert AM; Francis CJ; Bouvier M; Tesmer JJ; Sterne-Marr R
    J Biol Chem; 2014 Sep; 289(36):25262-75. PubMed ID: 25049229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modeling of human leptin/leptin receptor complex.
    Hiroike T; Higo J; Jingami H; Toh H
    Biochem Biophys Res Commun; 2000 Aug; 275(1):154-8. PubMed ID: 10944457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation.
    Mirza S; Walker A; Chen J; Murphy JM; Young IG
    Biochem J; 2010 Feb; 426(3):307-17. PubMed ID: 20078425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the interaction between interleukin-13 and interleukin-13 receptors.
    Arima K; Sato K; Tanaka G; Kanaji S; Terada T; Honjo E; Kuroki R; Matsuo Y; Izuhara K
    J Biol Chem; 2005 Jul; 280(26):24915-22. PubMed ID: 15870068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phocid seal leptin: tertiary structure and hydrophobic receptor binding site preservation during distinct leptin gene evolution.
    Hammond JA; Hauton C; Bennett KA; Hall AJ
    PLoS One; 2012; 7(4):e35395. PubMed ID: 22536379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.